Fujii et al. (2021) discovered that defects in sphingomyelin synthase 1 lead to thrombocytopenia, which aligns with our finding that Sphingomyelin level is a protective factor for ITP. This evidence concerns the gene SGMS1 and autoimmune thrombocytopenic purpura.